Implementing Dyslipidemia Guidelines into Clinical Practice Following an Acute Coronary Syndrome: Challenges and Opportunities for Improvement

作者：Alisha Labinaz, R. Yao, Farshad Hosseini, Ricky D. Turgeon, Miles Marchand, Liam R. Brunham, Nathaniel M. Hawkins, Graham C. Wong, G.B. John Mancini, Christopher B. Fordyce · 发表于：CJC Open · 年份：2025 · DOI：10.1016/j.cjco.2025.06.021 · 被引用次数：5 · 研究领域：Lipoproteins and Cardiovascular Health、Antiplatelet Therapy and Cardiovascular Diseases、Acute Myocardial Infarction Research

Following an acute coronary syndrome (ACS), patients remain at a residual increased risk of adverse cardiovascular events. As such, secondary prevention strategies, including dyslipidemia management, are key in the delivery of post-ACS care. Multiple randomized controlled trials have highlighted the benefit of lipid-lowering therapies in reducing low-density lipoprotein cholesterol levels, an independent predictor of adverse cardiovascular events post-ACS. However, registries have demonstrated that post-ACS, a significant proportion of patients are not achieving guideline-recommended low-density lipoprotein target levels, and intensification of lipid-lowering therapies continues to be underutilized. This review assesses strategies in which post-ACS lipid management can be improved, in particular by standardizing follow-up care through dedicated post-ACS clinics.